51吃瓜网

Home

Neuro Staff Appreciation Day 2025

Thursday, September 4, 2025 11:00to14:00

Staff Appreciation Day is exclusively for Neuro staff, faculty, nurses, students, and trainees. ID required to enter./neuroCategory:聽MNI Staff

Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

Thursday, September 25, 2025 16:00to17:00

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research./neuroCategory:聽Medicine and Health Sciences MNI

6th National Course on Sleep Medicine

Friday, November 28, 2025 09:00toSaturday, November 29, 2025 16:00

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.3801 rue University, Montreal, QC, H3A 2B4, CA/neuroCategory:聽Medicine Research...

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

Thursday, November 13, 2025 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro鈥檚 premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

Alan Evans receives Order of Canada

Published: 30 June 2025

Career of breakthroughs in neuroimaging recognized with one of the nation鈥檚 highest honours ...

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Pages

Subscribe to Undergraduate Students RSS
Back to top